» Articles » PMID: 20182617

P53 Regulation of the IGF-1/AKT/mTOR Pathways and the Endosomal Compartment

Overview
Date 2010 Feb 26
PMID 20182617
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

In response to various stress signals, which introduce infidelity into the processes of cell growth and division, p53 initiates cell-cycle arrest, apoptosis, or senescence to maintain fidelity throughout the cell cycle. Although these functions are traditionally thought of as the major functions of the p53 protein for tumor suppression, recent studies have revealed some additional novel functions of the p53 pathway. These include the down-regulation of two central cell-growth pathways, the IGF/AKT-1 and mTOR pathways, and the up-regulation of the activities of the endosomal compartment. The IGF-1/AKT and mTOR pathways are two evolutionarily conserved pathways that play critical roles in regulation of cell proliferation, survival, and energy metabolism. In response to stress, p53 transcribes a group of critical negative regulators in these two pathways, including IGF-BP3, PTEN, TSC2, AMPK beta1, and Sestrin1/2, which leads to the reduction in the activities of these two pathways. Furthermore, p53 transcribes several critical genes regulating the endosomal compartment, including TSAP6, Chmp4C, Caveolin-1, and DRAM, and increases exosome secretion, the rate of endosomal removal of growth factor receptors (e.g., EGFR) from cell surface, and enhances autophagy. These activities all function to slow down cell growth and division, conserve and recycle cellular resources, communicate with adjacent cells and dendritic cells of the immune system, and inform other tissues of the stress signals. This coordinated regulation of IGF-1/AKT/mTOR pathways and the endosomal compartment by the p53 pathway integrates the molecular, cellular, and systemic levels of activities and prevents the accumulations of errors in response to stress and restores cellular homeostasis after stress.

Citing Articles

Regulatory Roles of Exosomes in Aging and Aging-Related Diseases.

Xiao N, Li Q, Liang G, Qian Z, Lin Y, Zhang H Biogerontology. 2025; 26(2):61.

PMID: 39966192 DOI: 10.1007/s10522-025-10200-7.


Bayesian identification of differentially expressed isoforms using a novel joint model of RNA-seq data.

Shi X, Wang X, Jin L, Halakivi-Clarke L, Clarke R, Neuwald A PLoS Comput Biol. 2025; 21(1):e1012750.

PMID: 39888956 PMC: 11819608. DOI: 10.1371/journal.pcbi.1012750.


Menopause mysteries: the exosome-inflammation connection.

Sultania A, Brahadeeswaran S, Kolasseri A, Jayanthi S, Tamizhselvi R J Ovarian Res. 2025; 18(1):12.

PMID: 39849635 PMC: 11756133. DOI: 10.1186/s13048-025-01591-9.


Identification of hub biomarkers and immune cell infiltrations participating in the pathogenesis of endometriosis.

Li K, Wang J, Liu X, Dang Y, Wang K, Li M Sci Rep. 2025; 15(1):2802.

PMID: 39843899 PMC: 11754470. DOI: 10.1038/s41598-025-86164-y.


A system-level model reveals that transcriptional stochasticity is required for hematopoietic stem cell differentiation.

Herrera J, Bensussen A, Garcia-Gomez M, Garay-Arroyo A, Alvarez-Buylla E NPJ Syst Biol Appl. 2024; 10(1):145.

PMID: 39639033 PMC: 11621455. DOI: 10.1038/s41540-024-00469-8.


References
1.
Grahame Hardie D . New roles for the LKB1-->AMPK pathway. Curr Opin Cell Biol. 2005; 17(2):167-73. DOI: 10.1016/j.ceb.2005.01.006. View

2.
Inoki K, Corradetti M, Guan K . Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet. 2004; 37(1):19-24. DOI: 10.1038/ng1494. View

3.
Von Zastrow M, Sorkin A . Signaling on the endocytic pathway. Curr Opin Cell Biol. 2007; 19(4):436-45. PMC: 1992519. DOI: 10.1016/j.ceb.2007.04.021. View

4.
Vogelstein B, Lane D, Levine A . Surfing the p53 network. Nature. 2000; 408(6810):307-10. DOI: 10.1038/35042675. View

5.
Yoo L, Chung D, Yuan J . LKB1--a master tumour suppressor of the small intestine and beyond. Nat Rev Cancer. 2002; 2(7):529-35. DOI: 10.1038/nrc843. View